Both in Pharmaceuticals
Zymeworks vs Schrodinger
Over the past year ZYME returned +56.6% and SDGR returned +35.9%; their daily moves had a correlation of 0.23.
ZYME +56.6% SDGR +35.9%Growth of $1, one year, split-adjusted
| Metric | ZYME | SDGR |
|---|---|---|
| Price | $28.92 | $30.12 |
| Market cap | $2.08B | $2.25B |
| Today | +0.24% | +12.72% |
| 1 month | +6.3% | −0.7% |
| 6 months | +3.9% | +156.1% |
| Year to date | +9.8% | +68.5% |
| 1 year | +56.6% | +35.9% |
| Revenue growth (YoY) | −90.6% | +7.5% |
| Gross margin | 100.0% | 55.1% |
| Net margin | −980.8% | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | 56.0× | 8.7× |
| Net cash | $270.7M | $413.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.0% | 90.9% |
| Short % of float | 13.0% | 19.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).